Kai Pharmaceuticals, Inc.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

127 documents for Kai Pharmaceuticals, Inc.

- KAI Pharmaceuticals Announces Advancement of KAI-4169 Clinical Program into a Phase 2 Trial.
...-- KAI Pharmaceuticals, Inc., a privately held drug discovery and development ...
- Business Wire
- March 14, 2011
- KAI Pharmaceuticals Announces Late Breaker Poster Presentation of KAI-4169 Phase 2 Clinical Results at the American Society of Nephrology's Kidney Week 2011.
...-- KAI Pharmaceuticals, Inc., a privately held drug discovery and development ...
- Business Wire
- November 11, 2011
- Keynote Speakers and Industry Thought-Leaders Announce Their Participation in the 13th Annual C21 BioVenturesTM.
...This year's stellar program includes opportunities to hear from leading venture capital... Applied Integrin Science; Aquinox Pharmaceuticals Inc.; Ascendis Pharma A/S; Del Mar Pharmaceuticals...
- Business Wire
- March 30, 2011

- Research and Markets: Spinal Cord Injury Global Clinical Trials Review Q1 2011.
...It includes an overview of the trial numbers and their recruit...* Pfizer Inc. * Bayer AG. * KAI Pharmaceuticals Inc. * Merck Co & Inc. * Medtronic Neurological. *...
- Business Wire
- February 24, 2011
- Reportlinker Adds Small Molecule Kinase Inhibitors.
...The report profiles 83 companies including many key and niche players worldwide such as Amgen..., Inc., GlaxoSmithKline plc., KAI Pharmaceuticals, Inc., Merck & Co., Inc., Mitsubishi Tanabe Pharma...
- Business Wire
- July 16, 2009
- BIO Announces Selection of 2009 Presenting Companies for 8th Annual BIO Investor Forum.
...The advisory committee includes: . * Benjamin R. Bowen, Ph.D., Rodman & Renshaw, L...(ADXS) Affectis Pharmaceuticals AG Alchemia Ltd. (ACL) Allon Therapeutics Inc. (NP...
- Business Wire
- September 01, 2009
- C21 BioVentures (C21) Continues to Stand Out as the Premier Private Life Science Company Conference.
.... Jeffrey Bacha, Kalgene Pharma Inc. commented: . "Thank you for a great opportunity. ...; AnaptysBio, Inc.; ApopLogic Pharmaceuticals, LLC; Armune BioScience, Inc.; Arzeda Corporation;...
- Business Wire
- April 27, 2009
- Formatech to Donate Services to Manufacture KAI Pharmaceuticals' Clinical Candidate Under Its 'Fillanthropy[TM] Program'.
... that they have selected KAI Pharmaceuticals, Inc. and their KAI-4169 compound as the second clinica...
- Business Wire
- November 18, 2009
- BIO Announces Business Forum Company Presentations at the 2010 BIO International Convention.
... therapeutic and industry tracks, including leading biotechnology & pharmaceutical companies, ...(ASTM) Addex Pharmaceuticals (SIX: ADXN) Adolor Corp. (ADLR) Affectis Pharmaceu...
- Business Wire
- April 08, 2010
- Final Call to Register for BioPartnering Europe (BPE).
... only maximise attendees opportunities to increase their profile within the biotechnology sector, but..., ACE BioSciences A/S, Aerie Pharmaceuticals, Inc, Addex Pharmaceuticals, Affitech AS/ Affitech...
- Business Wire
- October 02, 2008